These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of amantadine on motor memory consolidation in humans. Hadj Tahar A; Blanchet PJ; Doyon J Behav Pharmacol; 2005 Mar; 16(2):107-12. PubMed ID: 15767846 [TBL] [Abstract][Full Text] [Related]
3. Modulation of human motor cortex excitability by single doses of amantadine. Reis J; John D; Heimeroth A; Mueller HH; Oertel WH; Arndt T; Rosenow F Neuropsychopharmacology; 2006 Dec; 31(12):2758-66. PubMed ID: 16794570 [TBL] [Abstract][Full Text] [Related]
4. Plasma amantadine concentrations in patients with Parkinson's disease. Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813 [TBL] [Abstract][Full Text] [Related]
5. Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers. Wezenberg E; Verkes RJ; Ruigt GS; Hulstijn W; Sabbe BG Neuropsychopharmacology; 2007 Jun; 32(6):1272-83. PubMed ID: 17119538 [TBL] [Abstract][Full Text] [Related]
6. Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study. da Silva-Júnior FP; Braga-Neto P; Sueli Monte F; de Bruin VM Parkinsonism Relat Disord; 2005 Nov; 11(7):449-52. PubMed ID: 16154788 [TBL] [Abstract][Full Text] [Related]
7. Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine. Deep P; Dagher A; Sadikot A; Gjedde A; Cumming P Synapse; 1999 Dec; 34(4):313-8. PubMed ID: 10529725 [TBL] [Abstract][Full Text] [Related]
8. Failure to engage spatial working memory contributes to age-related declines in visuomotor learning. Anguera JA; Reuter-Lorenz PA; Willingham DT; Seidler RD J Cogn Neurosci; 2011 Jan; 23(1):11-25. PubMed ID: 20146609 [TBL] [Abstract][Full Text] [Related]
9. A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function. McEvoy JP J Clin Psychiatry; 1987 Sep; 48 Suppl():20-3. PubMed ID: 2887553 [TBL] [Abstract][Full Text] [Related]
10. The effect of amantadine on corneal endothelium in subjects with Parkinson's disease. Chang KC; Jeong JH; Kim MK; Wee WR; Lee JH; Jeon BS Ophthalmology; 2010 Jun; 117(6):1214-9. PubMed ID: 20153901 [TBL] [Abstract][Full Text] [Related]
12. Motor procedural learning in Parkinson's disease. Muslimovic D; Post B; Speelman JD; Schmand B Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374 [TBL] [Abstract][Full Text] [Related]
13. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers. Hindmarch ; Shamsi Z Curr Med Res Opin; 2001; 17(4):273-81. PubMed ID: 11922401 [TBL] [Abstract][Full Text] [Related]
15. The NMDA antagonist memantine affects training induced motor cortex plasticity--a study using transcranial magnetic stimulation. Schwenkreis P; Witscher K; Pleger B; Malin JP; Tegenthoff M BMC Neurosci; 2005 May; 6():35. PubMed ID: 15890074 [TBL] [Abstract][Full Text] [Related]
16. Amantadine and other antiglutamate agents: management of Parkinson's disease. Mov Disord; 2002; 17 Suppl 4():S13-22. PubMed ID: 12211136 [No Abstract] [Full Text] [Related]
17. Quantitative determination of amantadine in human plasma by liquid chromatography-mass spectrometry and the application in a bioequivalence study. Wang P; Liang YZ; Chen BM; Zhou N; Yi LZ; Yu Y; Yi ZB J Pharm Biomed Anal; 2007 Mar; 43(4):1519-25. PubMed ID: 17156962 [TBL] [Abstract][Full Text] [Related]
18. Altered bidirectional plasticity and reduced implicit motor learning in concussed athletes. De Beaumont L; Tremblay S; Poirier J; Lassonde M; Théoret H Cereb Cortex; 2012 Jan; 22(1):112-21. PubMed ID: 21572090 [TBL] [Abstract][Full Text] [Related]
19. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers. Barbanoj MJ; García-Gea C; Morte A; Izquierdo I; Pérez I; Jané F Neuropsychobiology; 2004; 50(4):311-21. PubMed ID: 15539863 [TBL] [Abstract][Full Text] [Related]